About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Kotak Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD.14.970735200062.6877
Domestic EquitiesCipla Ltd.6.776918500028.3772
Domestic EquitiesDivis Laboratories Ltd.5.30683600022.2217
Domestic EquitiesINNOVA CAPTABS LTD4.344817803518.1934
Domestic EquitiesJUBILANT PHARMOVA LIMITED4.126614000017.2795
Domestic EquitiesORCHID PHARMA LIMITED4.003610000016.7645
Domestic EquitiesJB Chemicals & Pharmaceuticals Ltd.3.93699500016.4854
Domestic EquitiesApollo Hospitals Enterprise Ltd.3.91402400016.3894
Domestic EquitiesMax Healthcare Institute Ltd.3.907416700016.3618
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.88994900016.2886
Domestic EquitiesAurobindo Pharma Ltd.3.648512100015.2775
Domestic EquitiesDr.Reddy's Laboratories Ltd.3.589112500015.0288
Domestic EquitiesLupin Ltd.3.52627200014.7654
Domestic EquitiesAlkem Laboratories Ltd.3.23402400013.5419
Domestic EquitiesAjanta Pharma Ltd.2.84233937711.9019
Domestic EquitiesGlenmark Pharmaceuticals Ltd2.73807500011.4649
Domestic EquitiesZydus Lifesciences Ltd.2.652811500011.1084
Domestic EquitiesASTER DM HEALTHCARE LTD2.567021500010.7489
Domestic EquitiesKrsnaa Diagnostics Ltd2.37751000009.9555
Domestic EquitiesAmi Organics Ltd2.3030450009.6433
Domestic EquitiesFortis Healthcare India Ltd2.12531350008.8992
Domestic EquitiesKRISHNA INSTITUTE OF MEDICAL2.11191500008.8433
Domestic EquitiesHIKAL LTD2.06522100008.6478
Domestic EquitiesMarksans Pharma Ltd2.04632500008.5688
Domestic EquitiesEMCURE PHARMACEUTICALS LIMITED1.6001490846.7000
Domestic EquitiesBiocon Ltd.1.56091790006.5362
Domestic EquitiesGlaxosmithkline Pharma Ltd1.5178260006.3554
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.4607560006.1163
Total 99.1441 415.1527
Cash & Cash Equivalents and Net AssetsTriparty Repo1.3371 5.5990
Cash & Cash Equivalents and Net AssetsNet Current Assets/(Liabilities)-0.4812 -2.0151
Total 0.8559 3.5839
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.